The drug that has been approved by the National Institute for Health and Care Excellence (Nice) is called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo).

Women’s health experts issue warning on limitations of ‘miracle’ endometriosis pill - Debilitating condition affects around 1.5 million women in the UK ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...